• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Orexo

21.00 SEK

0.00 %

Less than 1K followers

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
+13.64 %
-11.58 %
-30.23 %
-9.68 %
+5.63 %
+113.85 %
-46.84 %
-76.65 %

Orexo is a Swedish pharmaceutical company that develops improved medicines based on proprietary formulation technologies and with a focus on meeting major medical needs. In the US market, Orexo commercializes treatments for patients suffering from opioid addiction. Products targeting other therapeutic areas are developed and commercialized worldwide through partners.

Read more
Market cap
780.29M SEK
Turnover
91.6K SEK
Revenue
26M
EBIT %
-1,356.54 %
P/E
1.14
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16/7
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

4/2
2027

Annual report '26

Press release6/9/2026, 6:00 AM

Orexo utser Raheleh Nassaji till SVP Business Development och stärker sitt fokus på nya partnerskap

Orexo
Press release6/9/2026, 6:00 AM

Orexo appoints Raheleh Nassaji as SVP Business Development, strengthening its focus on new partnerships

Orexo
Press release5/19/2026, 9:38 AM

DNB Carnegie Access: Orexo: Promising early-stage data

Orexo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/19/2026, 6:00 AM

Orexo meddelar positiva data från en in-vivo-studie med OX390

Orexo
Press release5/19/2026, 6:00 AM

Orexo announces positive outcome from an in-vivo study of OX390

Orexo
Regulatory press release5/7/2026, 3:00 PM

Kommuniké från Orexo AB:s årsstämma den 7 maj 2026

Orexo
Regulatory press release5/7/2026, 3:00 PM

Report from Orexo AB’s annual general meeting May 7 2026

Orexo
Press release4/29/2026, 6:40 AM

DNB Carnegie Access: Orexo: Better visibility, few near-term catalysts – Q1 review

Orexo
Regulatory press release4/28/2026, 5:00 AM

Orexo Delårsrapport Kv 1 2026

Orexo
Regulatory press release4/28/2026, 5:00 AM

Orexo Q1 2026 Interim Report

Orexo
Press release4/21/2026, 8:00 AM

Inbjudan till presentation av Orexos delårsrapport för kv 1 2026

Orexo
Press release4/21/2026, 8:00 AM

Invitation to presentation of Orexo´s Q1 2026 Interim Report

Orexo
Regulatory press release3/31/2026, 3:30 PM

Antal aktier och röster i Orexo

Orexo
Regulatory press release3/31/2026, 3:30 PM

Number of shares and votes in Orexo

Orexo
Press release3/30/2026, 10:00 AM

Kallelse till årsstämma i Orexo

Orexo
Press release3/30/2026, 10:00 AM

Notice of Annual General Meeting of Orexo

Orexo
Regulatory press release3/27/2026, 9:00 AM

Orexo publicerar årsredovisning för 2025

Orexo
Regulatory press release3/27/2026, 9:00 AM

Orexo publishes Annual Report for 2025

Orexo
Press release3/24/2026, 6:53 PM

DNB Carnegie Access: Orexo: Key takeaways from R&D Day

Orexo
Regulatory press release3/24/2026, 1:25 PM

Finansinspektionen: Flaggningsmeddelande i Orexo AB

Orexo